Abstract:Rhenium-186 (186Re) labeled nanoliposome (RNL) therapy for recurrent glioblastoma patients has shown promise to improve outcomes by locally delivering radiation to affected areas. To optimize the delivery of RNL, we have developed a framework to predict patient-specific response to RNL using image-guided mathematical models. Methods: We calibrated a family of reaction-diffusion type models with multi-modality imaging data from ten patients (NCR01906385) to predict the spatio-temporal dynamics of each patient's tumor. The data consisted of longitudinal magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT) to estimate tumor burden and local RNL activity, respectively. The optimal model from the family was selected and used to predict future growth. A simplified version of the model was used in a leave-one-out analysis to predict the development of an individual patient's tumor, based on cohort parameters. Results: Across the cohort, predictions using patient-specific parameters with the selected model were able to achieve Spearman correlation coefficients (SCC) of 0.98 and 0.93 for tumor volume and total cell number, respectively, when compared to the measured data. Predictions utilizing the leave-one-out method achieved SCCs of 0.89 and 0.88 for volume and total cell number across the population, respectively. Conclusion: We have shown that patient-specific calibrations of a biology-based mathematical model can be used to make early predictions of response to RNL therapy. Furthermore, the leave-one-out framework indicates that radiation doses determined by SPECT can be used to assign model parameters to make predictions directly following the conclusion of RNL treatment. Statement of significance: This manuscript explores the application of computational models to predict response to radionuclide therapy in glioblastoma. There are few, to our knowledge, examples of mathematical models used in clinical radionuclide therapy. We have tested a family of models to determine the applicability of different radiation coupling terms for response to the localized radiation delivery. We show that with patient-specific parameter estimation, we can make accurate predictions of future glioblastoma response to the treatment. As a comparison, we have shown that population trends in response can be used to forecast growth from the moment the treatment has been delivered.In addition to the high simulation and prediction accuracy our modeling methods have achieved, the evaluation of a family of models has given insight into the response dynamics of radionuclide therapy. These dynamics, while different than we had initially hypothesized, should encourage future imaging studies involving high dosage radiation treatments, with specific emphasis on the local immune and vascular response.

Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling

Biologically-Based Mathematical Modeling of Tumor Vasculature and Angiogenesis via Time-Resolved Imaging Data

Image-based personalization of computational models for predicting response of high-grade glioma to chemoradiation

Three-dimensional image-based mechanical modeling for predicting the response of breast cancer to neoadjuvant therapy

Predicting Radiotherapy Patient Outcomes with Real-Time Clinical Data Using Mathematical Modelling

A kinetic model of tumor growth and its radiation response with an application to Gamma Knife stereotactic radiosurgery

Quantitative in vivo imaging to enable tumor forecasting and treatment optimization

Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes

Nimg-55. Developing A Computational Pipeline To Forecast And Spatially Map High-Grade Glioma Response To Radiotherapy Using Biophysical Models And Data-Driven Statistical Analysis

Spatiotemporal multi-scale modeling of radiopharmaceutical distributions in vascularized solid tumors

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation

Mathematical Modeling and Analysis of Tumor-Volume Variation During Radiotherapy

Bayesian Inference of Tissue Heterogeneity for Individualized Prediction of Glioma Growth

Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model

Automatic MRI-Driven Model Calibration for Advanced Brain Tumor Progression Analysis

Mathematical modeling of radiotherapy: impact of model selection on estimating minimum radiation dose for tumor control

A Population-Based Tumor-Volume Model for Head and Neck Cancer During Radiation Therapy With a Dynamic Oxygenated Compartment

A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies

Personalized Predictions of Glioblastoma Infiltration: Mathematical Models, Physics-Informed Neural Networks and Multimodal Scans